Fas-Induced Apoptosis Is a Rare Event in Sjögren's Syndrome

Berke, 1995, The CTL's kiss of death, Cell, 81, 9, 10.1016/0092-8674(95)90365-8 Bolstad, 2000, FasFas ligand gene polymorphisms in primary Sjögren's syndrome, J Rheumatol, 27, 2397 Bursch, 1990, The biochemistry of cell death by apoptosis, Biochem Cell Biol, 68, 1071, 10.1139/o90-160 Daniels, 1984, Labial salivary gland biopsy in Sjögren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases, Arthritis Rheum, 27, 147, 10.1002/art.1780270205 Gavrieli, 1992, Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation, J Cell Biol, 119, 493, 10.1083/jcb.119.3.493 Greenspan, 1974, The histopathology of Sjögren's syndrome in labial salivary gland biopsies, Oral Surg Oral Med Oral Pathol, 37, 217, 10.1016/0030-4220(74)90417-4 Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189 Hahne, 1996, Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape, Science, 274, 1363, 10.1126/science.274.5291.1363 Halse, 1999, Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome, Clin Exp Immunol, 115, 203, 10.1046/j.1365-2249.1999.00778.x Halse, 1999, Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome, Scand J Immunol, 49, 533, 10.1046/j.1365-3083.1999.00533.x Halse, 2000, Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome, Scand J Rheumatol, 29, 13, 10.1080/030097400750001752 Henkart, 1994, Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules, Immunity, 1, 343, 10.1016/1074-7613(94)90063-9 Hsu, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661 Humphreys-Beher, 1999, An alternative perspective to the immune response in autoimmune exocrinopathy: Induction of functional quiescence rather than destructive autoaggression, Scand J Immunol, 49, 7, 10.1046/j.1365-3083.1999.00490.x Huppertz, 1999, The apoptosis cascade: Morphological and immunohistochemical methods for its visualization, Anat Embryol (Berl), 200, 1, 10.1007/s004290050254 Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5 Jonsson, 2000, Sjögren's syndrome, Arthritis and allied conditions: A textbook of rheumatology, 14 ed Jonsson, 1993, Progression of sialadenitis in Sjögren's syndrome, Br J Rheumatol, 32, 578, 10.1093/rheumatology/32.7.578 Kiefer, 1995, Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak, Nature, 374, 736, 10.1038/374736a0 Kong, 1998, Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: Involvement of Bax in salivary gland destruction, Clin Immunol Immunopathol, 88, 133, 10.1006/clin.1998.4556 Kong, 1997, Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome, Arthritis Rheum, 40, 87, 10.1002/art.1780400113 Korsmeyer, 1992, Bcl-2 initiates a new category of oncogenes: Regulators of cell death, Blood, 80, 879, 10.1182/blood.V80.4.879.879 Labat-Moleur, 1998, TUNEL apoptotic cell detection in tissue sections: Critical evaluation and improvement, J Histochem Cytochem, 46, 327, 10.1177/002215549804600306 Loro, 1999, Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis, Hum Pathol, 30, 1097, 10.1016/S0046-8177(99)90229-0 Manganelli, 1997, Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome, J Rheumatol, 24, 1552 Matsumura, 1996, Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome, Clin Exp Rheumatol, 14, 309 Matsumura, 1998, Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome, Clin Exp Rheumatol, 16, 561 Mountz, 1996, The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases, Clin Immunol Immunopathol, 80, S2, 10.1006/clin.1996.0136 Mullauer, 2000, Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer, J Pathol, 190, 20, 10.1002/(SICI)1096-9896(200001)190:1<20::AID-PATH497>3.0.CO;2-S Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 Nakamura, 1998, Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: Comparison with human T lymphotropic virus-I (HTLV-I)- seronegative and -seropositive SS patients, Clin Exp Immunol, 114, 106, 10.1046/j.1365-2249.1998.00692.x Negoescu, 1996, In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations, J Histochem Cytochem, 44, 959, 10.1177/44.9.8773561 Oehm, 1992, Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen, J Biol Chem, 267, 10709, 10.1016/S0021-9258(19)50076-X Polihronis, 1998, Modes of epithelial cell death and repair in Sjögren's syndrome (SS), Clin Exp Immunol, 114, 485, 10.1046/j.1365-2249.1998.00705.x Reichlin, 1989, Autoimmune response to the Ro/SSA particle is directed to the human antigen, Clin Exp Immunol, 76, 373 Saas, 1997, Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain, J Clin Invest, 99, 1173, 10.1172/JCI119273 Skarstein, 1997, Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis, Scand J Immunol, 46, 373, 10.1046/j.1365-3083.1997.d01-142.x Suda, 1995, Expression of the Fas ligand in cells of T cell lineage, J Immunol, 154, 3806, 10.4049/jimmunol.154.8.3806 Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169, 10.1016/0092-8674(93)90326-L Sumida, 1997, TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome, J Immunol, 158, 1020, 10.4049/jimmunol.158.2.1020 Surh, 1994, T-cell apoptosis detected in situ during positive and negative selection in the thymus, Nature, 372, 100, 10.1038/372100a0 Taga, 1993, IL-10 inhibits apoptotic cell death in human T cells starved of IL-2, Int Immunol, 5, 1599, 10.1093/intimm/5.12.1599 Takahashi, 1994, Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell, 76, 969, 10.1016/0092-8674(94)90375-1 Tengnér, 1998, Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome, Arthritis Rheum, 41, 2238, 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464 Vitali, 1993, Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community, Arthritis Rheum, 36, 340, 10.1002/art.1780360309 Watanabe-Fukunaga, 1992, Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature, 356, 314, 10.1038/356314a0 Yasuda, 1995, Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method, Arch Histol Cytol, 58, 185, 10.1679/aohc.58.185 Zeher, 1999, Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome, Arthritis Rheum, 42, 1673, 10.1002/1529-0131(199908)42:8<1673::AID-ANR16>3.0.CO;2-1 Zha, 1996, Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2, J Biol Chem, 271, 7440, 10.1074/jbc.271.13.7440 Halse, 1999, Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome, Clin Exp Immunol, 115, 208, 10.1046/j.1365-2249.1999.00779.x